Cosmos Health Commences U.S. Operations, Entering $164B Nutraceuticals Market with Its Sky Premium Life Brand; Expects 75% Gross Margins and Strong Cash Flow, with NOOR Collagen Alone Projected to Generate Over $12M in Annualized Revenue

Core Viewpoint - Cosmos Health Inc. has officially launched its U.S. operations with the introduction of its proprietary Sky Premium Life food supplements brand, marking a significant milestone in its expansion strategy into the world's largest nutraceuticals market [1][7]. Company Overview - Cosmos Health Inc. is a diversified, vertically integrated global healthcare group, incorporated in 2009 in Nevada, with a portfolio of proprietary pharmaceutical and nutraceutical brands [8]. - The company operates through subsidiaries in Europe and North America, focusing on manufacturing pharmaceuticals, food supplements, cosmetics, and medical devices [8]. Product Launch and Sales - The Sky Premium Life NOOR Collagen product, formulated with premium marine collagen tripeptide, is now available in the U.S. and is designed to support skin and joint health [3][5]. - Early sales momentum for NOOR Collagen is encouraging, with projections indicating it could generate over $12 million in annualized revenue [5][7]. Market Potential - The U.S. nutraceuticals market was valued at $163.7 billion in 2024 and is expected to grow at a CAGR of 6.2% through 2030, driven by increasing health awareness and demand for natural wellness solutions [6]. - The company anticipates strong gross margins of approximately 75% from its U.S. operations, indicating significant cash flow generation potential [5]. Strategic Commitment - Cosmos Health emphasizes its commitment to regulatory excellence and product integrity by manufacturing all Sky Premium Life products in GMP-certified, FDA-registered U.S. facilities [2]. - The launch of NOOR Collagen is the first step in a series of planned product introductions aimed at meeting strong consumer demand in the U.S. market [8].